SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Muhammad Waqar, Asad U. Khan, Habib U. Rehman, Muhammad Idrees, Muhammad Wasim, Amjad Ali, Zeeshan Niaz, Zobia Ismail, Mujaddad U. Rehman, Muhammad Tariq, Muqarrab Shah, Bibi N. Murtaza, Determination of hepatitis C virus genotypes circulating in different districts of Punjab (Pakistan), European Journal of Gastroenterology & Hepatology, 2014, 26, 1, 59

    CrossRef

  2. 2
    JULES L. DIENSTAG, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  3. 3
    Geoffrey Dusheiko, Tabinda Burney, Current treatment of chronic HBV infection: A European perspective, Current Hepatitis Reports, 2009, 8, 4, 141

    CrossRef

  4. 4
    Christophe M. Olinger, Bernard Weber, Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact / Genetische Variabilität des Hepatitis B Virus S Gens: Einfluss auf Klinik und Diagnostik, LaboratoriumsMedizin, 2009, 33, 4, 210

    CrossRef

  5. 5
    Winnie Yeo, Hepatitis B virus reactivation in association with antineoplastic therapy, Current Hepatitis Reports, 2009, 8, 3, 127

    CrossRef

  6. 6
    Tin Nguyen, Paul Desmond, Stephen Locarnini, The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B, Hepatology International, 2009, 3, S1, 5

    CrossRef

  7. 7
    Jules L. Dienstag, Hepatitis B Virus Infection, New England Journal of Medicine, 2008, 359, 14, 1486

    CrossRef

  8. 8
    Ira M. Jacobson, Therapeutic Options for Chronic Hepatitis B: Considerations and Controversies, The American Journal of Gastroenterology, 2006, 101, S1, S13

    CrossRef

  9. 9
    Bernard Weber, Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact, Journal of Clinical Virology, 2005, 32, 2, 102

    CrossRef

  10. 10
    G. Y. MINUK, A. J. COHEN, N. ASSY, M. MOSER, Viral hepatitis and the surgeon, HPB, 2005, 7, 1
  11. 11
    B. Weber, The diagnostic and clinical impact of the genetic variability of the S (surface) gene of hepatitis B virus / Diagnostische und klinische Relevanz der genetischen Variabilität des S- (surface) Gens des Hepatitis B Virus, LaboratoriumsMedizin, 2004, 28, 1, 56

    CrossRef

  12. 12
    Mehmet Cindoruk, Tarkan Karakan, Efficacy of interferon alfa and lamivudine combination therapy versus interferon alfa monotherapy in Turkish patients with chronic hepatitis B: A double-blind, randomized, comparative study, Current Therapeutic Research, 2002, 63, 3, 167

    CrossRef

  13. 13
    Jung Mi Oh, Ms. Jinok Kyun, Sung Cho, Long-Term Lamivudine Therapy for Chronic Hepatitis B in Patients with and without Cirrhosis, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002, 22, 10
  14. 14
    Kenneth R. Hirsch, Teresa L. Wright, Practical Guidelines in Antiviral Therapy, 2002,

    CrossRef

  15. 15
    Winnie Yeo, Paul K.S. Chan, Sheng Zhong, Wing M. Ho, Joyce L. Steinberg, John S. Tam, Pun Hui, Nancy W.Y. Leung, Benny Zee, Philip J. Johnson, Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors, Journal of Medical Virology, 2000, 62, 3
  16. 16
    Sanjay Ramrakhiani, Bruce R. Bacon, HEPATOLOGY IN THE NEW MILLENNIUM, Medical Clinics of North America, 2000, 84, 5, 1085

    CrossRef

  17. 17
    Jules L. Dienstag, Eugene R. Schiff, Teresa L. Wright, Robert P. Perrillo, Hie-Won L. Hann, Zachary Goodman, Lynn Crowther, Lynn D. Condreay, Mary Woessner, Marc Rubin, Nathaniel A. Brown, Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States, New England Journal of Medicine, 1999, 341, 17, 1256

    CrossRef

  18. 18
    Winnie Yeo, Joyce L. Steinberg, John S. Tam, Paul K.S. Chan, Nancy W.Y. Leung, Kwok C. Lam, Tony S.K. Mok, Philip J. Johnson, Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy, Journal of Medical Virology, 1999, 59, 3
  19. 19
    Francis Yao, Robert G. Gish, Treatment of chronic hepatitis B: New antiviral therapies, Current Gastroenterology Reports, 1999, 1, 1, 20

    CrossRef

  20. 20
    Kim Krogsgaard, Patrick Marcellin, Christian Trepo, Pierre Berthelot, José M Sanchez-Tapias, Maggie Bassendine, Albert Tran, Denis Ouzan, Helmer Ring-Larsen, Johan Lindberg, Jaime Enriquez, Jean-Pierre Benhamou, Niels Bindslev, Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B, Journal of Hepatology, 1996, 25, 6, 803

    CrossRef

  21. 21
    Kim Krogsgaard, Erik Christensen, Niels Bindslev, Solko Schalm, Per Kragh Andersen, Helmer Ring-Larsen, Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B, Journal of Hepatology, 1996, 25, 6, 795

    CrossRef

  22. 22
    Jules L. Dienstag, Robert P. Perrillo, Eugene R. Schiff, Maria Bartholomew, Catherine Vicary, Marc Rubin, A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection, New England Journal of Medicine, 1995, 333, 25, 1657

    CrossRef

  23. 23
    David H. Van Thiel, Harlan I. Wright, Stefano Fagiuoli, Liver transplantation for hepatitis B virus—associated cirrhosis: A progress report, Hepatology, 1994, 20, S7
  24. 24
    Cristiana Barbera, Flavia Bortolotti, Carlo Crivellaro, Alessandra Coscia, Lucia Zancan, Paolo Cadrobbi, Gabriella Nebbia, Maria Nazarena Pillan, Loredana Lepore, Teresa Parrella, Giuseppe Dastoli, Maurizia R. Brunetto, Ferruccio Bonino, Recombinant interferon-α2a hastens the rate of HBeAg clearance in children with chronic hepatitis B, Hepatology, 1994, 20, 2
  25. 25
    Boris Yoffe, Christine A. Noonan, Hepatitis B virus, Digestive Diseases and Sciences, 1992, 37, 1, 1

    CrossRef